The Department of Health and Human Services Releases 2023 Final Exchange Rules & Guidance for Health Issuers
As the deadline for submission of Qualified Health Plans (QHPs) approaches, the Department of Health and Human Services (HHS) released the final 2023 Notice of Benefit and Payment Parameters (NBPP) ...
COVID-19 Lessons Learned Inform Retrospectives of State Responses and Pandemic Preparedness
By Rawson Pino and Margot Thistle As COVID-19 became a national pandemic in the United States in early 2020, states across the country scrambled to respond with public health strategies ...
The Department of Health and Human Services Releases 2023 Draft Marketplace Rules & Guidance for Health Issuers
On December 28, 2021, the Department of Health and Human Services (HHS) released the Proposed 2023 Notice of Benefit and Payment Parameters (NBPP), along with accompanying technical guidance on risk ...
Reflections on 2021 and Predictions for 2022
In our last edition of the 2021 calendar year, the Health Policy News team looks back at major health policy-related topics from the last year, as well as discusses the ...
NASHP Conference Features COVID-19 Updates and Forward-Looking Policy Discussions
Nearly every panel at this year’s annual National Academy of State Health Policy (NASHP) conference—which took place from September 20-22—inevitably included some focus on the implications and impact of the ...
ARP Includes Significant Funding Opportunity for States to Invest in HCBS
This special, two-part piece is dedicated to Section 9817 of the American Rescue Plan, which provides funding for home and community-based services (HCBS) programs. In part one, view a guide ...
Update on Vermont’s Efforts to Implement Wholesale Importation of Prescription Drugs from Canada
The COVID-19 pandemic has impacted many state policy efforts over the last year, with state agencies across the U.S. re-deploying their staff towards tracing and vaccination work. This has undoubtedly contributed to less momentum on drug importation efforts at the state ...
California Eyes Generic Drug Production to Curb Prescription Drug Costs
California has long been an innovator in prescription drug cost control efforts. In 2017, the state passed SB 17, a piece of drug pricing legislation with multiple reporting requirements aimed ...
Prescription Drug Pricing Reform Efforts Continue
This post marks the first in a planned series of updates from Health Policy News on prescription drug cost control measures. In this month’s installment, we highlight ongoing efforts through ...
First-of-Its-Kind Tennessee Block Grant Approved by CMS
On January 8th, 2021, the Center for Medicare and Medicaid Services (CMS) announced the approval of Tennessee’s final Medicaid Block grant proposal[1] which the state had originally submitted in 2019. ...